Application 206534

Type
ANDA
Sponsor
ZYDUS PHARMS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL120MGNoNo
002DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL180MGNoNo
003DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL240MGNoNo
004DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL300MGNoNo
005DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL360MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-6155diltiazem hydrochloridediltiazem hydrochlorideA-S Medication SolutionsANDACurrent
68382-595diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-595diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-595diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-596diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-596diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-596diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-597diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-597diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-597diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-598diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-598diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-598diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-599diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-599diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-599diltiazem hydrochloridediltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68788-7634diltiazem hydrochloridediltiazem hydrochloridePreferred Pharmaceuticals Inc.ANDACurrent
68788-7634diltiazem hydrochloridediltiazem hydrochloridePreferred Pharmaceuticals Inc.ANDACurrent
70518-2071diltiazem hydrochloridediltiazem hydrochlorideREMEDYREPACK INC.ANDACurrent
70771-1030diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1030diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1030diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1031diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1031diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1031diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1032diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1032diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1032diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1033diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1033diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1033diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1034diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1034diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1034diltiazem hydrochloridediltiazem hydrochlorideCadila Healthcare LimitedANDACurrent

Documents

DocumentSubmission typeDate
49367ORIG2017-08-15